KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Invested Capital (2018 - 2025)

ClearPoint Neuro's Invested Capital history spans 13 years, with the latest figure at $15.9 million for Q3 2025.

  • For Q3 2025, Invested Capital fell 45.26% year-over-year to $15.9 million; the TTM value through Sep 2025 reached $15.9 million, down 45.26%, while the annual FY2024 figure was $25.4 million, 18.55% down from the prior year.
  • Invested Capital for Q3 2025 was $15.9 million at ClearPoint Neuro, down from $19.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $52.7 million in Q2 2022 and bottomed at $15.9 million in Q3 2025.
  • The 5-year median for Invested Capital is $42.5 million (2023), against an average of $36.9 million.
  • The largest annual shift saw Invested Capital soared 19686.08% in 2021 before it tumbled 55.13% in 2025.
  • A 5-year view of Invested Capital shows it stood at $48.8 million in 2021, then dropped by 4.11% to $46.8 million in 2022, then tumbled by 33.36% to $31.2 million in 2023, then decreased by 18.55% to $25.4 million in 2024, then tumbled by 37.48% to $15.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Invested Capital are $15.9 million (Q3 2025), $19.7 million (Q2 2025), and $20.0 million (Q1 2025).